tDCS for Acquired Brain Injury

Kennedy Krieger Institute, Baltimore, MD
Acquired Brain Injury+1 More ConditionstDCS - Device
Eligibility
5 - 17
All Sexes
What conditions do you have?
Select

Study Summary

This trial will explore whether transcranial direct current stimulation is a safe and tolerable intervention for children with acquired brain injury, as well as whether EEG can predict response to the intervention.

Eligible Conditions
  • Acquired Brain Injury
  • Disorders of Consciousness

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

5 Primary · 3 Secondary · Reporting Duration: Up to 4 months

Day 5
Family Feedback Form
Day 7
Changes in adverse events (skin problems and/or seizures) as a measure of safety
Day 7
Changes in pain and discomfort as a measure of safety and tolerability
Up to 26 Days
Changes in EEG-Event-Related Potential (ERP)
Changes in Resting-State EEG (Coherence)
Disruption of Care Form
Number of participants with adverse events as related to tDCS
Up to 4 months
Changes in Neurobehavioral functioning

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

3 Treatment Groups

2-mA tDCS
1 of 3
1-mA tDCS
1 of 3
Sham tDCS
1 of 3

Experimental Treatment

10 Total Participants · 3 Treatment Groups

Primary Treatment: tDCS · No Placebo Group · N/A

2-mA tDCS
Device
Experimental Group · 1 Intervention: tDCS · Intervention Types: Device
1-mA tDCS
Device
Experimental Group · 1 Intervention: tDCS · Intervention Types: Device
Sham tDCS
Device
Experimental Group · 1 Intervention: tDCS · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
tDCS
2017
Completed Phase 2
~760

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 4 months

Who is running the clinical trial?

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.Lead Sponsor
83 Previous Clinical Trials
24,498 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,115 Previous Clinical Trials
32,578,759 Total Patients Enrolled
Stacy J Suskauer, MDPrincipal InvestigatorHugo W. Moser Research Institute at Kennedy Krieger, Inc.

Eligibility Criteria

Age 5 - 17 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have had a brain injury in the past.
References

Frequently Asked Questions

Are researchers currently seeking out participants for this experiment?

"Affirmative. According to the records on clinicaltrials.gov, this experiment is accepting participants as of now. It was initially posted November 13th 2019 and has been updated most recently on March 14th 2022. The researchers require 10 individuals from a single site for participation in the trial.." - Anonymous Online Contributor

Unverified Answer

Is this study open to individuals aged 20 and above?

"In accordance with the specified eligibility requirements, participants must be between 5 and 17 years of age." - Anonymous Online Contributor

Unverified Answer

How many people are actively participating in this medical experiment?

"Correct. According to clinicaltrials.gov, this medical experiment is still recruiting participants since its initial posting date of November 13th 2019 and last update on March 14th 2022; the study calls for 10 individuals from one site." - Anonymous Online Contributor

Unverified Answer

What are the qualifying criteria for participation in this research endeavor?

"This research study requires a maximum of 10 participants to have been diagnosed with some degree of consciousness disorder, and they must fall within the age bracket 5-17 years old." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.